Cardea is a vertically integrated manufacturer of minimally invasive catheter devices and complex delivery systems
Cirtec will incorporate Cardea into its NovelCath brand. (Credit: falco from Pixabay )
Cirtec Medical, an outsourcing partner for development of complex medical devices, has acquired US-based medical device contract development and manufacturing organisation (CMO) Cardea Catheter Innovations for an undisclosed sum.
Based in San Jose, California, Cardea is a vertically integrated manufacturer of minimally invasive catheter devices and complex delivery systems.
Cirtec will incorporate Cardea into its NovelCath brand, an interventional segment that focuses on structural heart, electrophysiology, and neurovascular applications.
Cardea CEO and founder Matyou Shahbaz said: “Joining Cirtec’s Interventional segment provides tremendous career opportunities for our team and enables us to support our customers with additional capabilities and competencies with a very experienced Cirtec team.”
Cardea, which has experience in design, development and manufacturing, offers braided and coiled reinforced catheter shafts, complex steerable and multi-directional sheath designs, medical balloons and microcatheters.
Cirtec is relocating its Los Gatos design centre and Cardea to a new 32,000ft² purpose-built facility in San Jose, California.
The San Jose facility will serve as Cirtec’s West Coast Centre of Excellence for catheters and delivery systems.
With a path to Cirtec Costa Rica production, the San Jose facility will offer catheter development, full device assembly, packaging, and volume manufacturing capabilities.
Cirtec CEO Brian Highley said: “This is an excellent opportunity for our organization, employees and most importantly our customers.
“This acquisition is a natural fit for us and serves as another example of our commitment to building our interventional capabilities for our customers following our investments into Vascotube and NovelCath.”
In May, Cirtec announced plans to expand its NovelCath manufacturing facility in Brooklyn Park, Minnesota. The expansion is expected to increase the facility size to more than 21,000ft2.